Skip to main content
. 1996 Nov 26;93(24):13814–13818. doi: 10.1073/pnas.93.24.13814

Figure 2.

Figure 2

Crosslinking of mIgM or mIgD stimulates ERK activity. (A) Effect of treatment of B104 cells with anti-IgM (•) or anti-IgD (○) (1 μg/ml) for the indicated times on ERK activity. (B) B104 cells were treated with either 0.5 μg/ml anti-IgM or 1.0 μg/ml anti-IgD. (Left) ERK activity measured at 3 min. (Right) Cell viability measured at 24 hr.